NasdaqCM - Nasdaq Real Time Price USD
Moleculin Biotech, Inc. (MBRX)
1.0300
-0.0200
(-1.90%)
At close: April 23 at 4:00:01 PM EDT
1.0600
+0.03
+(2.91%)
Pre-Market: 9:26:51 AM EDT
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-23,862
-23,862
-23,591
-27,639
-18,951
Investing Cash Flow
-13
-13
-124
-67
-19
Financing Cash Flow
4,635
4,635
4,141
-23
74,724
End Cash Position
4,278
4,278
23,550
43,145
70,903
Income Tax Paid Supplemental Data
--
--
--
--
15
Capital Expenditure
-13
-13
-124
-67
-19
Issuance of Capital Stock
4,660
4,660
4,166
--
74,684
Free Cash Flow
-23,875
-23,875
-23,715
-27,706
-18,970
12/31/2021 - 6/2/2016
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
CNSP CNS Pharmaceuticals, Inc.
0.9548
+7.04%
PHIO Phio Pharmaceuticals Corp.
2.0400
-18.73%
IVVD Invivyd, Inc.
0.6443
+4.61%
PSTV Plus Therapeutics, Inc.
0.9835
+24.97%
XLO Xilio Therapeutics, Inc.
0.7939
-1.99%
KTTA Pasithea Therapeutics Corp.
1.6300
+5.84%
RNAZ TransCode Therapeutics, Inc.
0.3140
+1.00%
EDSA Edesa Biotech, Inc.
2.3300
+1.30%
MIST Milestone Pharmaceuticals Inc.
1.1600
+9.43%
CAPR Capricor Therapeutics, Inc.
13.15
-5.33%